Literature DB >> 15005091

Is there more than one road to melanoma?

Jason K Rivers1.   

Abstract

CONTEXT: Sunlight is the main environmental cause of most cutaneous melanomas. Exposure to intense bursts of ultraviolet radiation, especially in childhood, starts the transformation of benign melanocytes into a malignant phenotype. Paradoxically, outdoor workers have a decreased risk of melanoma compared with indoor workers, suggesting that chronic sunlight exposure can have a protective effect. Further, some melanomas form on sun-exposed regions; others do not. Although some melanomas arise from pre-existing melanocytic naevi (moles), many arise de novo. These observations suggest that melanoma arises from multiple pathways, with initiating and promoting factors differing for each. STARTING POINT: Janet Maldonado and colleagues recently studied the distribution of BRAF gene mutations in 115 patients with invasive primary melanomas (J Natl Cancer Inst 2003; 95: 1878-80). These researchers found that BRAF mutations were statistically significantly more common in melanomas occurring on intermittently sun-exposed skin than elsewhere. By contrast, BRAF mutations in melanomas on chronically sun-damaged skin were rare. These findings strongly suggest that distinct genetic pathways lead to melanoma. WHERE NEXT? The study of gene-environment interactions is clearly the next arena for epidemiological research into melanoma. The recent identification of polymorphisms in the melanocortin-1 receptor could open up an avenue of investigation into a molecular distinction between those individuals whose melanomas arise on chronic sun-exposed skin from those in whom tumours will develop on sun-protected skin or from melanocytic naevi. If a dual pathway for melanoma is supported by other investigations, public-health messages can be tailored to the population at risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15005091     DOI: 10.1016/S0140-6736(04)15649-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Improving outcomes in advanced malignant melanoma: update on systemic therapy.

Authors:  Sarah Danson; Paul Lorigan
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort.

Authors:  Sungshim Lani Park; Loïc Le Marchand; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-13

3.  p15 Expression Differentiates Nevus from Melanoma.

Authors:  Laura A Taylor; Conor O'Day; Tzvete Dentchev; Kyle Hood; Emily Y Chu; Todd W Ridky; John T Seykora
Journal:  Am J Pathol       Date:  2016-11-14       Impact factor: 4.307

4.  Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial.

Authors:  Jean Y Tang; Teresa Fu; Erin Leblanc; Joann E Manson; David Feldman; Eleni Linos; Mara Z Vitolins; Nathalie C Zeitouni; Joseph Larson; Marcia L Stefanick
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

5.  Recent advances in sunlight-induced carcinogenesis using the Xiphophorus melanoma model.

Authors:  André A Fernandez; Lakshmi Paniker; Rachel Garcia; David L Mitchell
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-03-30       Impact factor: 3.228

Review 6.  Genetic and environmental melanoma models in fish.

Authors:  E Elizabeth Patton; David L Mitchell; Rodney S Nairn
Journal:  Pigment Cell Melanoma Res       Date:  2010-03-08       Impact factor: 4.693

7.  Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.

Authors:  Tatjana Abaffy; Robert Duncan; Daniel D Riemer; Olaf Tietje; George Elgart; Clara Milikowski; R Anthony DeFazio
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

8.  A population-based study of Australian twins with melanoma suggests a strong genetic contribution to liability.

Authors:  Sri N Shekar; David L Duffy; Philippa Youl; Amanda J Baxter; Marina Kvaskoff; David C Whiteman; Adèle C Green; Maria C Hughes; Nicholas K Hayward; Marylon Coates; Nicholas G Martin
Journal:  J Invest Dermatol       Date:  2009-04-09       Impact factor: 8.551

9.  The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.

Authors:  Amanda J Baxter; Maria Celia Hughes; Marina Kvaskoff; Victor Siskind; Sri Shekar; Joanne F Aitken; Adele C Green; David L Duffy; Nicholas K Hayward; Nicholas G Martin; David C Whiteman
Journal:  Twin Res Hum Genet       Date:  2008-04       Impact factor: 1.587

10.  [DNA copy number changes in the diagnosis of melanocytic tumors].

Authors:  J Bauer; B C Bastian
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.